Mitsui Chemicals details new financials and dental M&A strategy, shares on TSE in analyst focus
22.06.2026 - 20:36:43 | ad-hoc-news.de
By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-22, 20:34.
Mitsui Chemicals (JP3407800006) has published updated detailed consolidated financial statements and fresh strategy materials on its investor relations site, including a new focus on dental materials M&A as a third growth pillar alongside existing core businesses, according to its Tokyo Stock Exchange disclosure environment and IR documentation. IR overview page with latest documents
What Mitsui Chemicals just published
On 2026-06-22, Mitsui Chemicals released a "Detailed Consolidated Financial Statements" document for the latest period, providing a full breakdown of profit and loss, segment data, and cash flow figures in PDF form for investors following the TSE-listed stock. Earnings materials library with consolidated statements
This follows a 2026-06-19 Q&A summary from the CEO's May 2026 presentation, where management answered investor questions on demand trends, capital allocation, and portfolio strategy, offering additional qualitative context beyond the headline numbers in the earnings release.
Dental M&A as third growth pillar
On 2026-06-15, Mitsui Chemicals published a Life & Healthcare Solutions business strategy document describing plans to develop a "third growth pillar" through dental materials M&A, positioning oral care and restorative materials as a higher-margin, structural growth area within its portfolio. Strategy release on Life & Healthcare Solutions business
The strategy builds on the planned acquisition of Ultradent Products, announced on 2026-06-12 in a timely disclosure notice, which outlines agreements to acquire the US-based dental materials specialist as a platform asset in the global dental solutions market.
All news and analysis on the Mitsui Chemicals shares
Further documents, background reports and price data on Mitsui Chemicals can be found in the dedicated topic section and on the company’s investor relations pages.
The business behind the stock
Mitsui Chemicals generates revenue across performance materials, basic chemicals, and life & healthcare solutions, with key products including automotive polypropylene compounds, optical lens materials, agrochemicals, and a growing portfolio of dental restorative and adhesive materials serving clinics and laboratories worldwide.
Where the shares trade today
The Mitsui Chemicals shares (JP3407800006) trade on the Tokyo Stock Exchange, with the most recent available price data in Japanese yen referenced via official TSE and company disclosures.
Mitsui Chemicals at a glance
- Company: Mitsui Chemicals, Inc.
- ISIN: JP3407800006
- WKN: 863509
- Ticker: 4183
- Trading venue: TSE
- Price (as of 2026-06-21, 08:00): 3,000 JPY
- Market cap: 900,000,000,000 JPY (as of 2026-06-21)
- Sector / industry: Chemicals / diversified chemicals
- Index membership: Nikkei 225
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, investment recommendation, or an invitation to buy or sell securities. All data are based on sources considered reliable, but accuracy and completeness cannot be guaranteed. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions.
